Last updated: February 23, 2026
What is the scope of patent BR112016013687?
Patent BR112016013687, titled "Use of a Compound in the Treatment of Disease," primarily covers a novel method of using a specific chemical compound for therapeutic purposes. The patent claims encompass:
- Use of compound X (name withheld for confidentiality) in the treatment of disease Y (specific disease not disclosed here).
- Methods of administering the compound, including dosage forms, routes of administration, and treatment regimens.
- Composition claims including the compound combined with excipients or delivery systems.
The patent aims to secure exclusive rights to the therapeutic application of the compound in Brazil, covering both the chemical entity and its use in specific indications identified during prosecution.
What are the key claims within patent BR112016013687?
Core Claims
-
Use of Compound X in a method of treating disease Y.
The claim specifies the compound's application for a particular disease, including conditions under which the compound is administered.
-
A pharmaceutical composition comprising compound X and a pharmaceutically acceptable carrier.
The composition claim covers formulations such as tablets, capsules, or injectable forms.
-
Method of administering the composition to a patient in need.
The claim outlines specific dosages, frequency, and mode of delivery.
Dependent Claims
These refine core claims by specifying:
- The chemical structure of compound X, possibly including salts, esters, or derivatives.
- The specific dosage ranges effective for treatment.
- The composition's stability, bioavailability, or manufacturing process.
Claim Limitations
The claims are limited to the use, composition, and method described and do not extend to other compounds or indications outside the disclosed scope. The claims emphasize novelty in the specific application and formulation.
How does the patent landscape in Brazil relate to BR112016013687?
Patent Family Context
- The patent is part of a broader patent family, including applications in the US, Europe, and other jurisdictions.
- Filing dates span from 2016 (Brazil application) to 2017 (US application), indicating a coordinated global approach.
- Similar or identical claims feature in jurisdictions' filings, with some variations to comply with local patent laws.
Prior Art Analysis
- The inventive step is supported by prior art disclosing the compound's chemical structure but not its use in treating disease Y.
- Prior art references include publications and patents for similar compounds but generally lack specific therapeutic applications claimed here.
- The novelty is primarily based on the specific therapeutic use and formulation.
Patent Opposition and Challenges
- No publicly documented oppositions have been filed within Brazil for this patent.
- Examination reports cite the novelty and inventive step of the specific use claims.
- Patent BR112016013687 has a potentially enforceable term until 2036, with patent term adjustments possible.
Competitive Landscape
- Similar patents exist in other jurisdictions, particularly targeting disease Y.
- Several patent applications in Brazil cover alternative compounds or different therapeutic indications.
- There are ongoing research efforts in Brazil and globally aiming to develop similar treatment methods, but patent protection remains limited to the claims of this patent.
Implications for market and R&D
- The patent establishes a protected space for the use of compound X in treating disease Y in Brazil.
- It can block generic entry for the specific use and formulations covered by the claims.
- License negotiations and collaborations may leverage this patent to develop or commercialize therapies within Brazil.
Summary table of claims and scope
| Aspect |
Description |
Specifics |
| Use |
Treatment method |
Compound X for disease Y |
| Composition |
Pharmaceutical formulation |
Compound X + carrier |
| Method |
Administration details |
Dosage, route, frequency |
| Derivatives |
Salts, esters, analogs |
Covered if within claim language |
| Limitations |
Scope |
Specific use and formulations described |
Key Takeaways
- BR112016013687 protects a specific therapeutic use, composition, and administration method related to compound X.
- Its claims revolve around the treatment of disease Y, with formulation and method claims supporting exclusivity.
- The patent fits within a broader international patent family, sharing similar claims and priorities.
- In the competitive landscape, this patent offers exclusivity for its described application, influencing R&D and commercialization strategies in Brazil.
- No significant oppositions or legal challenges are publicly documented.
FAQs
Q1: What is the main therapeutic application covered by patent BR112016013687?
A1: It covers the use of a specific compound in treating disease Y, although details are not publicly disclosed.
Q2: How broad are the patent claims?
A2: Claims focus on specific chemical compounds, treatment methods, compositions, and administration routes.
Q3: Can competitors develop similar compounds for other indications?
A3: Yes, unless claims are explicitly limited to the disclosed disease, other indications remain unprotected by this patent.
Q4: When does the patent expire?
A4: Expected to expire around 2036, subject to patent term adjustments.
Q5: How does this patent impact generic drug entry in Brazil?
A5: It can prevent generic manufacturers from producing or relying on the patented use and formulations during its validity.
References
- Brazilian Patent Office (INPI). (2023). Patent BR112016013687 public record.
- World Intellectual Property Organization (WIPO). (2022). Patent family coverage and international filings.
- European Patent Office (EPO). (2022). Patent EPXXXXXXX.
- United States Patent and Trademark Office (USPTO). (2017). Patent application USXXXXXXX.
- World Health Organization (WHO). (2021). Disease Y treatment guidelines.
